Role of Bone Morphogenetic Protein 2 Polymorphisms in Bone Mineral Density after the Start of Treatment with Atorvastatin

Basic&Clinical Pharmacology&Toxicology, EarlyView.

Source: Basic and Clinical Pharmacology and Toxicology - August 2, 2018 Category: Drugs & Pharmacology Authors: Ricardo Usategui ‐Martín , Gemma Vega , Laura Abad‐Manteca , Marta Ruiz‐Mambrilla , Ismael Calero‐Paniagua , Antonio Dueñas‐Laita , José L. Pérez‐Castrillón Source Type: research